Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PFIZER INCPFE · Entity 2863 | Executive Vice President | May 12, 2022 | May 13, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PFIZER INC
Report date May 12, 2022 · Filed May 13, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 38,146 |
Reported balance
After 2022-05-12 transaction · row 1
1 source rowRow 1 · 2022-05-12 · Sale · Disposed 32,908 · Balance 38,146 |
| Common StockSEC Table I · non-derivative | IndirectBy Rule 16b-3 Plan | 2,914 |
Reported balance
Holding disclosure · report date 2022-05-12 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,914 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 12, 2022 Filed May 13, 2022 21:38 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 32,908 | $50.00 | $1,645,400.00 |
DisclosureSEC source: 0001225208-22-007019 · doc4.xml · nonDerivative · entry 1 Carapezzi William R JR · CIK 0001295078 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,146 Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 21:03 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 1,795 | $46.94 | $84,257.30 |
DisclosureSEC source: 0001225208-22-003668 · doc4.xml · nonDerivative · entry 4 Carapezzi William R JR · CIK 0001295078 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,054 F6 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 26, 2022 Filed Mar 1, 2022 21:03 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 21,193 | $0.00 Strike: $25.60 | $0.00 |
DisclosureSEC source: 0001225208-22-003668 · doc4.xml · derivative · entry 6 Carapezzi William R JR · CIK 0001295078 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,193 shares Expires 2022-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2022 Filed Mar 1, 2022 21:03 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 9,895 | $50.64 | $501,082.80 |
DisclosureSEC source: 0001225208-22-003668 · doc4.xml · nonDerivative · entry 3 Carapezzi William R JR · CIK 0001295078 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,849 F4 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F5 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 26, 2022 Filed Mar 1, 2022 21:03 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 4,619 | $47.72 | $220,418.68 |
DisclosureSEC source: 0001225208-22-003668 · doc4.xml · nonDerivative · entry 2 Carapezzi William R JR · CIK 0001295078 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,744 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. F3 · price: Price is the closing price of Pfizer common stock on February 25, 2022. Read SEC document |
| February 26, 2022 Filed Mar 1, 2022 21:03 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 21,193 | $25.60 | $542,540.80 |
DisclosureSEC source: 0001225208-22-003668 · doc4.xml · nonDerivative · entry 1 Carapezzi William R JR · CIK 0001295078 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,363 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 24, 2022 Filed Feb 25, 2022 22:06 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 20,073 | $0.00 Strike: $45.96 | $0.00 |
DisclosureSEC source: 0001225208-22-003459 · doc4.xml · derivative · entry 7 Carapezzi William R JR · CIK 0001295078 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,073 Underlying: Common Stock · 20,073 shares Expires 2029-02-24 F6 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F6 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 24, 2022 Filed Feb 25, 2022 22:06 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 22,823 | $0.00 Strike: $45.96 | $0.00 |
DisclosureSEC source: 0001225208-22-003459 · doc4.xml · derivative · entry 6 Carapezzi William R JR · CIK 0001295078 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,823 Underlying: Common Stock · 22,823 shares Expires 2027-02-24 F5 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F5 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 22:06 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 25,632 | $0.00 Strike: $27.34 | $0.00 |
DisclosureSEC source: 0001225208-22-003459 · doc4.xml · derivative · entry 5 Carapezzi William R JR · CIK 0001295078 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,632 shares Expires 2022-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 22:06 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 12,687 | $51.28 | $650,589.36 |
DisclosureSEC source: 0001225208-22-003459 · doc4.xml · nonDerivative · entry 3 Carapezzi William R JR · CIK 0001295078 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,170 F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 22:06 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 4,057 | $46.87 | $190,151.59 |
DisclosureSEC source: 0001225208-22-003459 · doc4.xml · nonDerivative · entry 2 Carapezzi William R JR · CIK 0001295078 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,857 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 22:06 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 25,632 | $27.34 | $700,778.88 |
DisclosureSEC source: 0001225208-22-003459 · doc4.xml · nonDerivative · entry 1 Carapezzi William R JR · CIK 0001295078 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,914 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 27, 2021 Filed Mar 2, 2021 22:35 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 21,570 | $0.00 Strike: $22.35 | $0.00 |
DisclosureSEC source: 0001225208-21-004301 · doc4.xml · derivative · entry 5 Carapezzi William R JR · CIK 0001295078 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,570 shares Expires 2021-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2021 Filed Mar 2, 2021 22:35 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 13,676 | $34.64 | $473,736.64 |
DisclosureSEC source: 0001225208-21-004301 · doc4.xml · nonDerivative · entry 3 Carapezzi William R JR · CIK 0001295078 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,861 F4 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F5 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 27, 2021 Filed Mar 2, 2021 22:35 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 2,985 | $33.49 | $99,967.65 |
DisclosureSEC source: 0001225208-21-004301 · doc4.xml · nonDerivative · entry 2 Carapezzi William R JR · CIK 0001295078 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,537 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. F3 · price: Price is the closing price of Pfizer common stock on February 26, 2021. Read SEC document |
| February 27, 2021 Filed Mar 2, 2021 22:35 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 21,570 | $22.35 | $482,089.50 |
DisclosureSEC source: 0001225208-21-004301 · doc4.xml · nonDerivative · entry 1 Carapezzi William R JR · CIK 0001295078 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,522 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 20:58 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 32,769 | $0.00 Strike: $33.82 | $0.00 |
DisclosureSEC source: 0001225208-21-004032 · doc4.xml · derivative · entry 7 Carapezzi William R JR · CIK 0001295078 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,769 Underlying: Common Stock · 32,769 shares Expires 2028-02-25 F6 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F6 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 20:58 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 37,925 | $0.00 Strike: $33.82 | $0.00 |
DisclosureSEC source: 0001225208-21-004032 · doc4.xml · derivative · entry 6 Carapezzi William R JR · CIK 0001295078 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,925 Underlying: Common Stock · 37,925 shares Expires 2026-02-25 F5 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F5 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 20:58 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 27,222 | $0.00 Strike: $22.89 | $0.00 |
DisclosureSEC source: 0001225208-21-004032 · doc4.xml · derivative · entry 5 Carapezzi William R JR · CIK 0001295078 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,222 shares Expires 2021-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 20:58 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 17,618 | $34.76 | $612,401.68 |
DisclosureSEC source: 0001225208-21-004032 · doc4.xml · nonDerivative · entry 3 Carapezzi William R JR · CIK 0001295078 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,952 F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 20:58 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 2,983 | $33.82 | $100,885.06 |
DisclosureSEC source: 0001225208-21-004032 · doc4.xml · nonDerivative · entry 2 Carapezzi William R JR · CIK 0001295078 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,570 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 20:58 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 27,222 | $22.89 | $623,111.58 |
DisclosureSEC source: 0001225208-21-004032 · doc4.xml · nonDerivative · entry 1 Carapezzi William R JR · CIK 0001295078 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,553 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 22, 2021 Filed Feb 23, 2021 23:12 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 1,410 | $34.26 | $48,306.60 |
DisclosureSEC source: 0001225208-21-003547 · doc4.xml · nonDerivative · entry 1 Carapezzi William R JR · CIK 0001295078 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,331 F1 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.